Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ACAD

Updated 10/6/2026, 10:27 AM ET.

ACAD

ACADIA PHARMACEUTICALS INC

Sale$587,242

Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

20,141 shat $29.16Filed Aug 7, 6:00 PM ET
Filing
ACAD

ACADIA PHARMACEUTICALS INC

Sale$432,663

Thompson Elizabeth H.Z.

EVP, Head of Research & Dev

16,558 shat $26.13Filed Jul 31, 6:00 PM ETFiling

Read from public SEC filings. Not financial advice.